| Date | Title | |
| 12/20/18 | Illumina to Webcast Upcoming Investor Conference Presentations |  |
| 12/06/18 | Illumina Announces a New Genotyping Array and Scientific Contribution to Three Genome Centers to Support the All of Us Research Program | |
| 11/13/18 | Illumina to Webcast Upcoming Investor Conference Presentations | |
| 11/01/18 | Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery | |
| 10/30/18 | Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling | |
| 10/23/18 | Illumina Reports Financial Results for Third Quarter of Fiscal Year 2018 | |
| 10/09/18 | Illumina to Announce Third Quarter 2018 Financial Results on Tuesday, October 23, 2018 | |
| 09/28/18 | Illumina Announces Conversion Period for 0% Convertible Senior Notes due 2019 and 0.5% Convertible Senior Notes due 2021 | |
| 08/30/18 | Illumina to Webcast Upcoming Investor Conference Presentation | |
| 08/27/18 | Illumina Receives Approval of MiSeq™Dx System in China | |
| 08/16/18 | Illumina Announces Pricing of Convertible Senior Notes | |
| 08/15/18 | Illumina to Offer $650 Million Convertible Senior Notes | |
| 07/30/18 | Illumina Reports Financial Results for Second Quarter of Fiscal Year 2018 | |
| 07/10/18 | Illumina to Announce Second Quarter 2018 Financial Results on Monday, July 30, 2018 | |
| 05/29/18 | Illumina to Webcast Upcoming Investor Conference Presentations | |
| 05/15/18 | Illumina Acquires Edico Genome to Accelerate Genomic Data Analysis | |
| 05/02/18 | Illumina to Webcast Upcoming Investor Conference Presentation | |
| 04/24/18 | Illumina Reports Financial Results for First Quarter of Fiscal Year 2018 | |
| 04/13/18 | Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion Diagnostics for Bristol-Myers Squibb’s Oncology Immunotherapies | |
| 04/10/18 | Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics | |
| 04/10/18 | Illumina to Announce First Quarter 2018 Financial Results on Tuesday, April 24, 2018 | |
| 03/12/18 | Illumina Names Dr. Phil Febbo Chief Medical Officer | |
| 02/27/18 | Illumina to Webcast Upcoming Investor Conference Presentation | |
| 01/30/18 | Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017 | |
| 01/26/18 | Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc. | |
| 01/16/18 | Illumina to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, January 30, 2018 | |
| 01/08/18 | Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology | |
| 01/08/18 | Illumina Launches iSeq 100 Sequencing System | |
| 01/04/18 | Illumina and KingMed Diagnostics Partner to Develop Next-Generation Sequencing Technology for Chinese FDA Approval | |
Receive E-mail Alerts | 
RSS Feeds